Spine News and Research

RSS

Zyga receives FDA approval to update indications for use of SImmetry system

Zyga Technology, Inc. announced today that the U.S. Food & Drug Administration (FDA) has approved the company's request to update the indications for use of its SImmetry Sacroiliac Joint Fusion System.

19 Aug 2011

Kensey Nash fourth quarter total revenues decrease 14% to $18.7 million

Kensey Nash Corporation, a medical device company primarily focused on regenerative medicine for a wide range of medical procedures, today reported the results for its fourth quarter and fiscal year ended June 30, 2011.

18 Aug 2011

OrthoSensor, Stryker partner for intelligent knee surgical trial

Stryker Corporation's Orthopaedics Division and OrthoSensor, Inc., the leader in intelligent orthopaedics, today announced an agreement in which OrthoSensor will provide the OrthoSensor Knee Trial, designed for use with Stryker's Triathlon Knee System.

From Stryker 18 Aug 2011

BioMedGPS launches enterprise-wide Business Intelligence Hub for life science industry

BioMedGPS, the leader in healthcare business intelligence and competitive metrics, today launched the first enterprise-wide Business Intelligence Hub for the life science industry.

17 Aug 2011

Patient recruitment complete in Kuros' KUR-023 dural sealant European clinical trial

Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced today that it has completed patient recruitment in a clinical trial investigating the safety and efficacy of KUR-023, its novel dural sealant product candidate.

17 Aug 2011

DJOFL second quarter net sales increase 14.5% to $277.8 million

DJO Global, Inc., a leading global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results for its operating subsidiary, DJO Finance LLC, for the second quarter of fiscal 2011, ended July 2, 2011.

16 Aug 2011

Novel assay can accurately detect prostate cancer than traditional screening

new prostate screening test developed by AnalizaDx, Inc., a Cleveland-based biotech company, and studied by researchers at the Seidman Cancer Center at University Hospitals (UH) Case Medical Center along with colleagues at the Cleveland Clinic, the Veterans Administration Boston Healthcare and the National Cancer Institute, may prove to be a promising new tool in the diagnosis of prostate cancer.

16 Aug 2011

Misonix adds MD Solutions to distribution network in Asia and the South Pacific

Misonix, Inc., a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide has entered into a new three-year exclusive distribution agreement with MD Solutions Australasia Pty. Ltd., based in Newport, Victoria, Australia.

12 Aug 2011

AANEM awards accreditation status to four UH Neuromuscular Center EMG labs

The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) has awarded accreditation status to four electromyography (EMG) laboratories affiliated with the University Hospitals (UH) Neuromuscular Center in Northeast Ohio.

12 Aug 2011

InVivo Therapeutics reports net loss of $1,370,000 for second quarter 2011

InVivo Therapeutics Holdings Corp., a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today reported financial results for the three and six months ended June 30, 2011 and provided a business update.

11 Aug 2011

Boston Scientific introduces NLI online resource center for healthcare providers

Boston Scientific Corporation has launched its Neuromodulation Learning Institute (NLI), a clinical education program and online resource center for healthcare providers to enhance their knowledge and awareness of spinal cord stimulation (SCS) technology, procedures and techniques.

11 Aug 2011

Study suggests link between gene variant and Proteus syndrome

Orthopaedic surgeons from Children's National Medical Center are part of a team of researchers that has identified the genetic mutation causing Proteus syndrome, a rare disorder in which tissue and bone grow massively out of proportion.

11 Aug 2011

Biomarker may signal whether common back pain treatment will work

A new study from researchers at the Stanford University School of Medicine has identified a unique protein complex that can be used to predict whether an epidural steroid injection will help relieve pain caused by a herniated disc in the lower spine.

10 Aug 2011

SANUWAVE second quarter revenues increase 40%

SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today reported financial results for the three and six months ended June 30, 2011 and provided a business update.

10 Aug 2011

Current Medical Research & Opinion publishes new data on EVISTA for postmenopausal osteoporosis

Eli Lilly and Company today announced that data on EVISTA® (raloxifene HCl tablets) therapy for more than three years was published online in Current Medical Research & Opinion.

10 Aug 2011

Soy useless for menopause

In their two year study they found that there were no differences in changes in bone density or menopausal symptoms between women taking soy and those taking a placebo, although women taking isoflavones did have more hot flashes, Dr. Silvina Levis of the University of Miami and colleagues reported in the August 8/22 issue of Archives of Internal Medicine.

8 Aug 2011

FDA approves Relievant IDE for Intracept System to treat chronic low back pain

Relievant Medsystems, Inc. today announced the company has received Food and Drug Administration approval of an Investigational Device Exemption to begin their SMART pivotal trial to evaluate the safety and effectiveness of the Intracept System for treatment of chronic low back pain.

8 Aug 2011

Allergan receives positive opinion from Irish Medicines Board for BOTOX

Allergan is pleased to announce that BOTOX has received a positive opinion from the Irish Medicines Board for the management of urinary incontinence in adults with neurogenic detrusor overactivity (NDO) resulting from neurogenic bladder due to stable sub-cervical spinal cord injury, or multiple sclerosis.

8 Aug 2011

Roundup: State workers in Conn. get lock on retirement health funds

State employees have never warmed to the idea of having to contribute a portion of their pay to help fund their retirement health care, and one of the arguments they make against it is the history of special accounts' being used as a piggybank by legislators and governors when money is tight.

6 Aug 2011

Life becomes harder after settlements for on-the-job back injuries

Financial and domestic problems for workers -- particularly those who are African-American, have lower incomes, or are younger than 35 -- get progressively worse in the years after they have settled claims for painful, on-the-job back injuries, a new Saint Louis University study finds.

2 Aug 2011